白癜风终生风险及影响:英国人群队列研究
基于英国初级保健数据库2004–2020年数据,新诊断白癜风患者9460例,80岁时累积终生发病率为0.92%(95%CI 0.90-0.94),亚裔人群风险最高(3.58%)。白癜风患者抑郁、焦虑、睡眠障碍、就诊次数及病假风险均轻度增加,不同族裔间影响相似。
要点
- 白癜风80岁累积终生发病率为0.92%,女性与男性相似。
- 亚裔终生发病率3.58%,显著高于白人0.73%。
- 患者抑郁、焦虑、睡眠障碍及病假风险轻度增加。
核心结论
- 白癜风终生发病率约0.92%,亚裔、黑人及混合族裔风险显著高于白人。
- 白癜风患者精神健康问题、就诊次数及病假风险轻度增加,不同族裔间影响相似。
研究设计与样本
- 回顾性观察性队列研究,使用英国Optimum Patient Care Database初级保健记录。
- 采用改良时间-事件模型估计80岁时终生发病率,并按族裔、性别和贫困程度分层。
主要发现
- 80岁时总体累积终生发病率为0.92%(95%CI 0.90-0.94)。
- 女性累积发病率为0.94%(95%CI 0.92-0.97),男性为0.89%(95%CI 0.86-0.92)。
- 亚裔终生发病率3.58%(95%CI 3.38-3.78),黑人2.18%(95%CI 1.85-2.50),混合/多种族2.03%(95%CI 1.58-2.47),其他1.05%(95%CI 0.94-1.17),白人0.73%(95%CI 0.71-0.76)。
- 与匹配对照相比,白癜风患者抑郁风险aOR 1.08(95%CI 1.01-1.15),焦虑aOR 1.19(95%CI 1.09-1.30),抑郁或焦虑aOR 1.10(95%CI 1.03-1.17),睡眠障碍aHR 1.15(95%CI 1.02-1.31)。
- 白癜风患者初级保健就诊次数增加(调整发病率比1.29,95%CI 1.26-1.32),病假风险增加(aHR 1.15,95%CI 1.06-1.24)。
临床怎么用
- 临床医生应意识到亚裔、黑人、混合/多种族及其他族裔人群白癜风发病率显著升高。
- 对白癜风患者应监测精神健康、睡眠及工作相关影响,识别需要额外支持者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vitiligo is an autoimmune skin disorder characterized by depigmented patches of skin, which can have significant psychological impacts. OBJECTIVES: To estimate the lifetime incidence of vitiligo, overall, by ethnicity and across other sociodemographic subgroups, and to investigate the impacts of vitiligo on mental health, work and healthcare utilization. METHODS: Incident cases of vitiligo were identified in the Optimum Patient Care Database of primary care records in the UK between 1 January 2004 and 31 December 2020. The lifetime incidence of vitiligo was estimated at age 80 years using modified time-to-event models with age as the timescale, overall and stratified by ethnicity, sex and deprivation. Depression, anxiety, sleep disturbance, healthcare utilization and work-related outcomes were assessed in the 2 years after vitiligo diagnosis and compared with matched controls without vitiligo. The study protocol for this retrospective observational study was registered with ClinicalTrials.gov (NCT06097494). RESULTS: In total, 9460 adults and children were newly diagnosed with vitiligo during the study period. The overall cumulative lifetime incidence was 0.92% at 80 years of age [95% confidence interval (CI) 0.90-0.94]. Cumulative incidence was similar in female (0.94%, 95% CI 0.92-0.97) and male patients (0.89%, 95% CI 0.86-0.92). There were substantial differences in lifetime incidence across ethnic groups, listed by Office for National Statistics criteria [Asian 3.58% (95% CI 3.38-3.78); Black 2.18% (95% CI 1.85-2.50); Mixed/multiple 2.03% (95% CI 1.58-2.47); Other 1.05% (95% CI 0.94-1.17); and White 0.73% (95% CI 0.71-0.76)]. Compared with matched controls, people with vitiligo had an increased risk of depression [adjusted odds ratio (aOR) 1.08, 95% CI 1.01-1.15]; anxiety (aOR 1.19, 95% CI 1.09-1.30); depression or anxiety (aOR 1.10, 95% CI 1.03-1.17); and sleep disturbance [adjusted hazard ratio (aHR) 1.15, 95% CI 1.02-1.31]. People with vitiligo also had a greater number of primary care encounters (adjusted incidence rate ratio 1.29, 95% CI 1.26-1.32) and a greater risk of time off work (aHR 1.15, 95% CI 1.06-1.24). There was little evidence of disparities in vitiligo-related impacts across ethnic subgroups. CONCLUSIONS: Clinicians should be aware of the markedly increased incidence of vitiligo in people belonging to Asian, Black, Mixed/multiple and Other groups. The negative impact of vitiligo on mental health, work and healthcare utilization highlights the importance of monitoring people with vitiligo to identify those who need additional support. Vitiligo is the most common pigmentary skin disorder that causes white patches of skin on the body. The condition can develop at any age. Most often, it starts in childhood. Living with vitiligo can be stressful. People with vitiligo can be at an increased risk of experiencing mental health conditions. We investigated how the risk and impact of vitiligo varies across different groups of people. We used anonymized medical records from general practices across the UK from 2004 to the end of 2020. We looked at how many people developed vitiligo. We also looked at how old people were when they were diagnosed. We compared the risk of developing vitiligo between female and male patients, and between different ethnic groups. We found that approximately 1 in 109 people will develop vitiligo over their lifetime. This risk is similar for both female and male individuals. There are striking differences between ethnic groups. People of Asian ethnicity have almost 5 times the risk of getting vitiligo than people belonging to White ethnic groups. One in 28 people of Asian ethnicity will develop vitiligo. We also found that vitiligo had a wide range of impacts. People with vitiligo have a greater risk of depression, anxiety and sleep disturbance. People with vitiligo have contact with their general practices more often. They also have more time off work than people without vitiligo. These impacts are similar for people of different ethnic groups. Our study shows the risk of vitiligo varies in different ethnic groups. Our results can help healthcare professionals identify people who may need more support.
引用
- Eleftheriadou V, Ahmed A, Nesnas J, et al. The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study. Br J Dermatol. 2024. PMID: 39018020. doi:10.1093/bjd/ljae282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。